Latest News and Press Releases
Want to stay updated on the latest news?
-
CARGO Therapeutics Provides Corporate Update
-
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
-
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma